HOME >> BIOLOGY >> NEWS
Common Childhood Virus Poses Threat To Adults, Research Shows

and less than 40 years old.

While 135 patients tested positive for RSV antibodies, only the 57 whose level of antibodies quadrupled over the course of a month were considered true cases of RSV for the study. In some patients, researchers noticed the effects of bacterial infection, which indicates they might have acquired a bacterial pneumonia along with or after RSV infection.

“Doctors used to think that adults who acquire RSV may get cold symptoms, not pneumonia,” said Murry. “But in fact, a third of the 57 RSV patients in this study had changes in their lung X-rays which were probably RSV-related.”

The RSV virus attacks the epithelial cells that line the airways in the lungs. It spreads as people cough up infected epithelial cells, so hand washing is the best way to limit the spread of RSV.

RSV is the leading cause of severe lower respiratory tract infection in infants and young children. According to Murry, nearly every child in the United States acquires RSV before the age of two, as their immune systems are developing. Adults most vulnerable to infection are those who have undergone chemotherapy or organ transplants, as well as those with HIV.

If a patient has a severe enough case of RSV to need the help of a breathing machine, doctors can treat the infection with Ribovarin, an anti-viral drug. Doctors dissolve the drug in saline, and patients inhale it through a mist.

Symptoms of RSV persist even after the patient is discharged from the hospital.

“When people go home, it may be a while before they feel completely better, because the damage to their airways will take at least 8 weeks to heal,” said Murry. “So they’ll remain kind of wheezy and a little short of breath for that time. Most people can go back to work as soon as they go home from the hospital.”

Murry said a normal person couldn’t easily tell whether they have RSV or just a nasty cold. One clue i
'"/>

Contact: Andrew R. Murry
Murry.1@osu.edu
614-293-8745
Ohio State University
29-Aug-1997


Page: 1 2 3

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Common Childhood Virus Poses Threat Adults Research Shows

(Date:4/13/2015)... 13, 2015  higi, a leading cloud-based consumer engagement ... fully engage with their communities around health and wellness, ... and secure API.  ... accessible, affordable, and convenient vehicle to receive validated health ... The API will allow higi,s trusted partners, ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
(Date:5/5/2015)... 2015  Renova™ Therapeutics, a biopharmaceutical company developing ... other chronic diseases, has engaged RAND Health Advisory ... reflect the healthcare patterns of multiple advanced heart ... used to characterize the impact the company,s lead ... groups of patients and the overall health care ...
(Date:5/5/2015)... WASHINGTON, D.C., USA (PRWEB) May 05, 2015 ... export regulations covering a wide range of key photonics ... are hampering global competitiveness of U.S. industry. To help ... webinar on 12 May on the proposed ... governs the commodities covered by International Traffic in Arms ...
(Date:5/5/2015)... SAN FRANCISCO, Calif. , May 5, 2015 /PRNewswire/ ... the treatment of cancer, today announced that Sean ... at the Credit Suisse Antibody Day in ... Wednesday, May 6. Dr. McCarthy will present an overview ... immunotherapy and Probody drug conjugate programs. About ...
(Date:5/5/2015)... College Station, TX (PRWEB) May 05, 2015 ... Pfizer were announced last week as recipients of ... Technology Innovation in recognition of their Portable, Continuous, ... system that integrates a small footprint, continuous processing ... GMP modules) to process API powders and inactive ...
Breaking Biology Technology:RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3
Cached News: